Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection.

ABSTRACT: Deleterious effects on the heart from chronic stimulation of beta-adrenergic receptors (betaARs), members of the 7 transmembrane receptor family, have classically been shown to result from Gs-dependent adenylyl cyclase activation. Here, we identify a new signaling mechanism using both in vitro and in vivo systems whereby beta-arrestins mediate beta1AR signaling to the EGFR. This beta-arrestin-dependent transactivation of the EGFR, which is independent of G protein activation, requires the G protein-coupled receptor kinases 5 and 6. In mice undergoing chronic sympathetic stimulation, this novel signaling pathway is shown to promote activation of cardioprotective pathways that counteract the effects of catecholamine toxicity. These findings suggest that drugs that act as classical antagonist

SUBMITTER: Noma T 

PROVIDER: S-EPMC1952636 | biostudies-literature | 2007 Sep

REPOSITORIES: biostudies-literature